Thursday
SESSION XIX: CRITICAL EVALUATION OF CAROTID ARTERY STENTING (CAS) IN NOVEMBER 2010 (5-MINUTE TALKS)
SESSION XIX SCHEDULE
2:22 PM - 2:27 PM Ten Top Tips For SAFE CAS: A Neuroradiologistís Perspective
  Presenters(s):Emmanuel M. Houdart, MD  
2:28 PM - 2:33 PM Debate 8: CREST Has Restored CAS To Its Rightful Place As Best Treatment For Most Carotid Stenoses: An Interventionalistís Perspective
  Presenters(s):William A. Gray, MD  
2:34 PM - 2:39 PM Debate 8: CREST May Be Helpful To Advocates Of CAS But It Is Not The Final Answer: When CEA, When CAS, When Best Medical Treatment (BMRx): A Surgeonís Perspective
  Presenters(s):Wesley S. Moore, MD  
2:40 PM - 2:45 PM Debate 8: Subanalysis Of CREST Results Are Important: Were There Differences Between CAS And CEA In 1) Quality Of Life And 2) Cost Effectiveness; What Were The Severity And Disability From The MIs And The Cranial Nerve Injuries: A Neurologistís Perspective
  Presenters(s):Thomas G. Brott, MD  
2:46 PM - 2:51 PM The Woes Of CAS Are Not Fully Solved By CREST: When Is CAS Justified And When And Why Is It Not?
  Presenters(s):Frank J. Criado, MD, FACS, FSVM  
2:52 PM - 2:57 PM Debate 9: We Do Not Need Any More CAS Trials After CREST And ICSS
  Presenters(s):Mark H. Wholey, MD  
2:58 PM - 3:03 PM Debate 9: We Need Additional CAS Trials And Why
  Presenters(s):Andrew N. Nicolaides, MS, FRCS  
3:04 PM - 3:09 PM Debate 10: Asymptomatic Carotid Stenosis Is Still An Indication For Treatment By CEA Or CAS In Most Patients Needing Aggressive Treatment (CABG Or PCI) For Coronary Artery Disease
  Presenters(s):John (Jeb) W. Hallett, MD  
3:10 PM - 3:15 PM Debate 10: Asymptomatic Carotid Stenosis Is Still An Indication For CEA Or CAS, In Some Patients Needing Aggressive Treatment (CABG Or PCI) For Coronary Artery Disease
  Presenters(s):John J. Ricotta, MD  
3:16 PM - 3:21 PM Debate 10: Most Patients Undergoing Cardiac Surgery With Asymptomatic Carotid Disease Do Not Benefit From A Synchronous Or Staged Carotid Intervention
  Presenters(s):A. Ross Naylor, MD, FRCS  
3:22 PM - 3:27 PM Panel Discussion
Moderator(s): Frank J. Veith, MD / Mark H. Wholey, MD  
3:27 PM - 3:32 PM Are There Neuropsychological Complications Of CAS Or CEA In The Absence Of Strokes?
  Presenters(s):Wei Zhou, MD  
3:33 PM - 3:38 PM CAS vs. CEA: What Are The DWI MRA, Brain Damage Markers And Neuropsychological Consequences Of The Two Procedures In Asymptomatic Patients: An Update
  Presenters(s):Laura Capoccia, MD  
3:39 PM - 3:44 PM SPACE II: The Most Needed Comparison Of CAS, CEA And BMRx For Asymptomatic Disease: Will It Provide Answers And When?
  Presenters(s):Hans-Henning Eckstein, MD, PhD  
3:45 PM - 3:50 PM When Is Cessation Or Reversal Of Brain Flow Protection A Must In CAS: What Are Its Disadvantages?
  Presenters(s):L. Nelson Hopkins, MD  
3:51 PM - 3:56 PM National Database Update On CEA vs. CAS For Symptomatic And Asymptomatic Disease: Are CAS Results Improving?
  Presenters(s):Mohammad H. Eslami, MD, RVT  
3:57 PM - 4:02 PM Serial Duplex Measurements Of Asymptomatic Carotid Lesions: Will They Help Identify Patients At Higher Risk For Stroke Who Will Benefit More From Invasive Treatment?
  Presenters(s):Alison Halliday, MS, FRCS  
4:03 PM - 4:08 PM How Can Asymptomatic Patients With Carotid Stenoses Be Identified To Be At High Stroke Risk In The Statin Era?
  Presenters(s):J. David Spence, MD  
4:09 PM - 4:15 PM Panel Discussion
4:15 PM - 4:25 PM Break Ė Visit Exhibits and Pavilions (2nd and 3rd Floors)
TOPICS PRESENTED BY TITLE: (SYNCHRONIZED TALKS, SLIDES AND ABSTRACTS THAT WILL BE AVAILABLE ON OUR WEB-BASED VERSION 5 WEEKS AFTER THE MEETING.)
Web-Based Presentation 19.1 - Toward Safer CAS: Tips And Tricks
  Presenters(s):Sumaira Macdonald, MBChB (Comm), FRCP, FRCR, PhD  
Web-Based Presentation 19.2 - Does The CRYSTALLO Variable Cell Size Stent Lower Embolic Event Rates With CAS?
  Presenters(s):Alberto Cremonesi, MD, FESC  
Web-Based Presentation 19.3 - Right Brachial Approach For Left Carotid Stenting With A Bovine Arch Anatomy
  Presenters(s):Patrick E. Muck, MD, RVT, FACS  
Web-Based Presentation 19.4 - Radial Approach For CAS: When, Why And How
  Presenters(s):Ali Amin, MD, RVT, FACS, FACC  
Web-Based Presentation 19.5 - Flaws In The Empire Trial
  Presenters(s):Michael H. Wholey, MD, MBA  
Web-Based Presentation 19.6 - Will The TACIT Trial Ever Be Done?
  Presenters(s):Barry T. Katzen, MD  
END OF SESSION XIX
previous next